Casdin Capital’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $411K | Hold |
36,493
| – | – | 0.04% | 31 |
|
|
2025
Q1 | $208K | Hold |
36,493
| – | – | 0.02% | 42 |
|
|
2024
Q4 | $358K | Hold |
36,493
| – | – | 0.02% | 37 |
|
|
2024
Q3 | $297K | Sell |
36,493
-1
| -0% | -$8 | 0.02% | 34 |
|
|
2024
Q2 | $488K | Hold |
36,494
| – | – | 0.04% | 36 |
|
|
2024
Q1 | $1.69M | Buy |
+36,494
| New | +$1.69M | 0.13% | 33 |
|
|
2022
Q2 | – | Sell |
-105,070
| Closed | -$16.9M | – | 44 |
|
|
2022
Q1 | $16.9M | Sell |
105,070
-3,152
| -3% | -$508K | 0.76% | 28 |
|
|
2021
Q4 | $36M | Sell |
108,222
-71,848
| -40% | -$23.9M | 1.01% | 29 |
|
|
2021
Q3 | $83.5M | Buy |
+180,070
| New | +$83.5M | 2.08% | 18 |
|